Ribavirin in the treatment of SARS: A new trick for an old drug?

This publication has 12 references indexed in Scilit:

• The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients
  Journal of Viral Hepatitis, 2003
• Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C
  Alimentary Pharmacology & Therapeutics, 2002
• The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase
  Current Opinion in Infectious Diseases, 2001
• Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
  The Lancet, 2001
• Intravenous Ribavirin and Hyperammonemia in an Immunocompromised Patient Infected with Adenovirus
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
• Adverse effects and other safety aspects of the hepatitis C antivirals
  Journal of Gastroenterology and Hepatology, 2000
• The clinical pharmacology of ribavirin.
  1999
• Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.
  1999
• Exposure of pregnant women to ribavirin-contaminated air
  The Pediatric Infectious Disease Journal, 1993
• Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome
  The Journal of Infectious Diseases, 1991